Vision Therapy Can Change Your Life…
Or the Life of Your Child

Vision Therapy at PressVision is a doctor supervised non-surgical treatment program that can in most cases successfully treat the following problems:

  • Lazy eye
  • Eye alignment problems
  • Focus problems
  • Convergence insufficiency
  • Hand-eye coordination problems
  • Double vision
  • Behavioral issues due to vision problems

It is not a “one-size fits all” solution – you get a therapy plan that is custom-tailored to your specific needs.

Meet Dr. Knapp – Vision Therapy Specialist

Dr. Laura Knapp

Dr. Knapp (O.D., F.C.O.V.D.) has been in the field of optometry for over 15 years – specializing in vision therapy. Her extensive training has allowed her to provide highly effective vision therapy treatment to hundreds of patients over the course of her career.

How Vision Therapy Works

1) Eye Exam
You will undergo an eye exam to make sure that Vision Therapy is an appropriate treatment option for your condition.

2) Your Unique Customized Program
If it is determined that Vision Therapy is right for you, a custom program will be developed based on the results of standardized tests, your needs and your symptoms.

3) Your Vision Therapy Sessions Begin
After your program has been created, you will come into PressVision where Dr. Knapp and her team will conduct your vision therapy sessions.

Your Vision Therapy Sessions:

  • Tyipcally 6-12 months
  • 1-2 Office Visits / Week
  • 30-60 minutes per visit
  • Occasional Exercises to Work on at Home

What You Can Expect

At the end of treatment, Vision Therapy allows you to develop efficient visual skills and processing. As a result, it can effectively treat a number of eye conditions (including lazy eye).

For children, Vision Therapy can improve the ability to process information – to learn – and as a result improve behavior. It is well known that children sometimes act out in educational environments out of frustration due to vision problems

Vision Therapy = Physical Therapy for your Eyes!

In some respects, vision therapy is like physical therapy for the eyes. Rather than treating the muscles of the body, it works on the eyes and visual system through eye-brain connections. It is an invaluable tool that changes not only the vision of our patients, but improves many related areas of their lives as well. It can literally be life changing!

The College of Optometrists in Vision Development (COVD) notes that vision therapy is generally conducted in-office, in once or twice weekly sessions of 30 minutes to an hour, occasionally supplemented with procedures done at home between office visits. You can view more information about vision therapy on the COVD website.

The Science Behind Vision Therapy

Vision occurs as collaboration between the eyes and the brain, informed by feedback from the rest of the body. The science of vision therapy is therefore rooted in the ability to guide an individual to make changes through feedback and awareness. As in any effective therapy, there must be a differential diagnostic process identifying which aspects of the visual system are mal-developed or in need of rehabilitation. Intervention can then be designed in accordance with generalized principles of therapy.

Vision Therapy Should Be Individualized and Customized

The science of therapy has established that to be maximally effective, therapy should be individualized and customized to the needs of the patient. Vision therapy may be implemented by a trained therapist, but must be administered under the supervision and guidance of a knowledgeable Doctor of Optometry. The patient must internalize changes and understand that the visual system is modified therapeutically, not by procedures done to the patient, rather to the extent the patient is responsible for viewing differently.

Technology has greatly aided the science of optometric vision therapy but placing the patient in front a computer cannot substitute for active observation and interaction with a therapist. In the next section we review research on vision therapy, but there is one major study that is crucial in understanding the science of vision therapy.

The CITT, or Convergence Insufficiency Treatment Trial, is a multicenter study funded by the National Institutes of Health (the original study name was CIRS, or Convergence Insufficiency and Reading Study). The group that created this study went on to publish the CISS, or Convergence Insufficiency Symptom Survey, to prove that pencil push-up therapy or base-in prism glasses used in isolation were NOT effective, and that home-alone therapy was equivalent to placebo therapy. This is where the science becomes pivotal. Anyone currently treating convergence insufficiency without the benefit of supplemental in-office procedures is essentially dispensing placebo therapy until proven otherwise.

Research on Vision Therapy

There are now many excellent compilations on the subject. Let’s start with a review, published in the highly regarded Cochrane Database Reviews on the National Center for Biotechnology Information’s Website. The citation is Scheiman M, Gwiazda J, Li T. Non-surgical interventions for convergence insufficiency. Cochrane Database Syst Rev 2011 Mar 16;(3):CD006768.

Office-based vision therapy is far superior to any other form of intervention

Convergence insufficiency, or CI, is a condition for which research has proven that office-based vision therapy is far superior to any other form of intervention. Two important points to keep in mind about this gold standard study, the citation for which is as follows:

Scheiman M, Cotter S, Mitchell GL, Kulp M, et al (CITT Study Group). Randomized clinical trial of treatments for symptomatic convergence insufficiency in children. Arch Ophthalmol 2008;126:1336-49.

A successful or improved outcome was found in 73% of the office-based therapy group, 43% of the pencil push-up group, and 35% of the office-based placebo therapy group, and 33% of the home-based computerized therapy group.

The results of this study are now being used by some insurance carriers to support the need for office-based vision therapy, but only of 12 weeks duration, as was used in the CITT study.

This demonstrates several very significant points about research on optometric vision therapy:

Unlike drug studies, in which the patient takes a placebo pill, it is challenging to design a placebo therapy group. Placebo therapy must be designed well enough that neither the patient nor the therapist knows that the therapy is not directly addressing the condition. The CITT group did a brilliant job designing this group, which is why they were able to generate such a good rate of improvement that came about from improving sustained visual attention – in fact, a couple of percentage points greater than the home-based computerized therapy group!

Although the outcome after 12 weeks of therapy was impressive at a 73% rate of improvement, we do not settle for that in our practice. Why would you want only a 73% rate of improvement if by going beyond 12 weeks, and/or adding additional procedures, you can generate a 95% rate of improvement?
Even if we take what the CITT has proven at face value, since ophthalmologists and pediatricians profess to practice only evidence-based medicine, that means that in the years since the CITT was published the field should have been transformed and have integrated the research outcomes of the CITT. Unfortunately for many patients in need, almost no pediatric ophthalmologists prescribe office-based vision therapy.